Cargando…

Myocardial Perfusion and Coronary Physiology Assessment of Microvascular Dysfunction in Patients Undergoing Transcatheter Aortic Valve Implantation—Rationale and Design

The prevalence of coronary artery disease (CAD) in patients with severe aortic stenosis (AS) is 30–68%. Nevertheless, there is still not enough evidence to use invasive assessment of lesion severity, because the hemodynamic milieu of AS may impact the fractional flow reserve (FFR) and non-hyperemic...

Descripción completa

Detalles Bibliográficos
Autores principales: Dobrolinska, M. M., Gąsior, P., Błach, A., Gocoł, R., Hudziak, D., Wojakowski, W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9775333/
https://www.ncbi.nlm.nih.gov/pubmed/36546930
http://dx.doi.org/10.3390/biomimetics7040230
_version_ 1784855618681569280
author Dobrolinska, M. M.
Gąsior, P.
Błach, A.
Gocoł, R.
Hudziak, D.
Wojakowski, W.
author_facet Dobrolinska, M. M.
Gąsior, P.
Błach, A.
Gocoł, R.
Hudziak, D.
Wojakowski, W.
author_sort Dobrolinska, M. M.
collection PubMed
description The prevalence of coronary artery disease (CAD) in patients with severe aortic stenosis (AS) is 30–68%. Nevertheless, there is still not enough evidence to use invasive assessment of lesion severity, because the hemodynamic milieu of AS may impact the fractional flow reserve (FFR) and non-hyperemic indices. Therefore, the aim of the study is two-fold. First, to measure acute and long-term changes of FFR, index of microvascular resistance (IMR), and coronary flow reserve (CFR) in patients undergoing TAVI procedure. Second, to compare the diagnostic accuracy of intracoronary indices with myocardial perfusion measured by cadmium-zinc-telluride single-photon emission tomography (CZT-SPECT) and find cut-off values defining significant stenosis. We plan to enroll 40 patients eligible for TAVI with intermediate stenosis (30–70%) in the left anterior descending (LAD) coronary artery. In each patient FFR, CFR, and IMR will be measured in addition to myocardial blood flow calculated by CZT-SPECT before and either immediately after TAVI (acute cohort) or in 6 months (late cohort) after the procedure. FFR, CFR, and IMR will be matched with the results of myocardial perfusion measured by CZT-SPECT in the area of LAD. As a result, cut-off values of FFR, CFR, and IMR defining the decreased blood flow will be found.
format Online
Article
Text
id pubmed-9775333
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-97753332022-12-23 Myocardial Perfusion and Coronary Physiology Assessment of Microvascular Dysfunction in Patients Undergoing Transcatheter Aortic Valve Implantation—Rationale and Design Dobrolinska, M. M. Gąsior, P. Błach, A. Gocoł, R. Hudziak, D. Wojakowski, W. Biomimetics (Basel) Study Protocol The prevalence of coronary artery disease (CAD) in patients with severe aortic stenosis (AS) is 30–68%. Nevertheless, there is still not enough evidence to use invasive assessment of lesion severity, because the hemodynamic milieu of AS may impact the fractional flow reserve (FFR) and non-hyperemic indices. Therefore, the aim of the study is two-fold. First, to measure acute and long-term changes of FFR, index of microvascular resistance (IMR), and coronary flow reserve (CFR) in patients undergoing TAVI procedure. Second, to compare the diagnostic accuracy of intracoronary indices with myocardial perfusion measured by cadmium-zinc-telluride single-photon emission tomography (CZT-SPECT) and find cut-off values defining significant stenosis. We plan to enroll 40 patients eligible for TAVI with intermediate stenosis (30–70%) in the left anterior descending (LAD) coronary artery. In each patient FFR, CFR, and IMR will be measured in addition to myocardial blood flow calculated by CZT-SPECT before and either immediately after TAVI (acute cohort) or in 6 months (late cohort) after the procedure. FFR, CFR, and IMR will be matched with the results of myocardial perfusion measured by CZT-SPECT in the area of LAD. As a result, cut-off values of FFR, CFR, and IMR defining the decreased blood flow will be found. MDPI 2022-12-08 /pmc/articles/PMC9775333/ /pubmed/36546930 http://dx.doi.org/10.3390/biomimetics7040230 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Study Protocol
Dobrolinska, M. M.
Gąsior, P.
Błach, A.
Gocoł, R.
Hudziak, D.
Wojakowski, W.
Myocardial Perfusion and Coronary Physiology Assessment of Microvascular Dysfunction in Patients Undergoing Transcatheter Aortic Valve Implantation—Rationale and Design
title Myocardial Perfusion and Coronary Physiology Assessment of Microvascular Dysfunction in Patients Undergoing Transcatheter Aortic Valve Implantation—Rationale and Design
title_full Myocardial Perfusion and Coronary Physiology Assessment of Microvascular Dysfunction in Patients Undergoing Transcatheter Aortic Valve Implantation—Rationale and Design
title_fullStr Myocardial Perfusion and Coronary Physiology Assessment of Microvascular Dysfunction in Patients Undergoing Transcatheter Aortic Valve Implantation—Rationale and Design
title_full_unstemmed Myocardial Perfusion and Coronary Physiology Assessment of Microvascular Dysfunction in Patients Undergoing Transcatheter Aortic Valve Implantation—Rationale and Design
title_short Myocardial Perfusion and Coronary Physiology Assessment of Microvascular Dysfunction in Patients Undergoing Transcatheter Aortic Valve Implantation—Rationale and Design
title_sort myocardial perfusion and coronary physiology assessment of microvascular dysfunction in patients undergoing transcatheter aortic valve implantation—rationale and design
topic Study Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9775333/
https://www.ncbi.nlm.nih.gov/pubmed/36546930
http://dx.doi.org/10.3390/biomimetics7040230
work_keys_str_mv AT dobrolinskamm myocardialperfusionandcoronaryphysiologyassessmentofmicrovasculardysfunctioninpatientsundergoingtranscatheteraorticvalveimplantationrationaleanddesign
AT gasiorp myocardialperfusionandcoronaryphysiologyassessmentofmicrovasculardysfunctioninpatientsundergoingtranscatheteraorticvalveimplantationrationaleanddesign
AT błacha myocardialperfusionandcoronaryphysiologyassessmentofmicrovasculardysfunctioninpatientsundergoingtranscatheteraorticvalveimplantationrationaleanddesign
AT gocołr myocardialperfusionandcoronaryphysiologyassessmentofmicrovasculardysfunctioninpatientsundergoingtranscatheteraorticvalveimplantationrationaleanddesign
AT hudziakd myocardialperfusionandcoronaryphysiologyassessmentofmicrovasculardysfunctioninpatientsundergoingtranscatheteraorticvalveimplantationrationaleanddesign
AT wojakowskiw myocardialperfusionandcoronaryphysiologyassessmentofmicrovasculardysfunctioninpatientsundergoingtranscatheteraorticvalveimplantationrationaleanddesign